Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.

Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.
复制标题

低分子量蛋白酪氨酸磷酸酶(LMWPTP)上调介导结直肠癌的恶性潜力。

DOI:
10.18632/oncotarget.3224
复制
发表时间:
2015-04-10
期刊:
影响因子:
--
通讯作者:
Fuhler GM
Fuhler GM
中科院分区:
其他
文献类型:
--
作者:
Hoekstra E;Kodach LL;Das AM;Ruela-de-Sousa RR;Ferreira CV;Hardwick JC;van der Woude CJ;Peppelenbosch MP;Ten Hagen TL;Fuhler GM

文献摘要

参考文献

被引文献

相似文献

长期以来,磷酸酶一直被认为是肿瘤抑制因子,然而,越来越多的证据表明,某些磷酸酶在几种形式的癌症中起肿瘤启动作用。低分子量蛋白酪氨酸磷酸酶(Low Molecular Weight Protein Tyrosine Phosphatase, LMWPTP; acid Phosphatase 1 [ACP1])是一种18 kDa的酶,可影响与癌症相关的信号通路介质的磷酸化,因此被认为是一种促肿瘤酶,但目前还没有明确的临床证据,也没有确定LMWPTP作用的令人信服的机制作用。在本研究中,我们发现LMWPTP的表达不仅在结直肠癌(CRC)中显著增加,而且在不同程度的不典型增生中也会逐步增加。化学抑制LMWPTP可显著降低结直肠癌的生长。此外,CRC中LMWPTP的下调导致2D和3d迁移测试中的迁移能力降低,并使肿瘤细胞对化疗药物5-FU敏感。综上所述,本研究表明LMWPTP不仅在结直肠癌中过表达,而且与结直肠癌的恶性潜能相关,提示该磷酸酶可能作为结直肠癌分期的预测生物标志物,是治疗结直肠癌的合理新靶点。
Phosphatases have long been regarded as tumor suppressors, however there is emerging evidence for a tumor initiating role for some phosphatases in several forms of cancer. Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP; acid phosphatase 1 [ACP1]) is an 18 kDa enzyme that influences the phosphorylation of signaling pathway mediators involved in cancer and is thus postulated to be a tumor-promoting enzyme, but neither unequivocal clinical evidence nor convincing mechanistic actions for a role of LMWPTP have been identified. In the present study, we show that LMWPTP expression is not only significantly increased in colorectal cancer (CRC), but also follows a step-wise increase in different levels of dysplasia. Chemical inhibition of LMWPTP significantly reduces CRC growth. Furthermore, downregulation of LMWPTP in CRC leads to a reduced migration ability in both 2D- and 3D-migration assays, and sensitizes tumor cells to the chemotherapeutic agent 5-FU. In conclusion, this study shows that LMWPTP is not only overexpressed in colorectal cancer, but it is correlated with the malignant potential of this cancer, suggesting that this phosphatase may act as a predictive biomaker of CRC stage and represents a rational novel target in the treatment of this disease.
PRL-3 通过 PRL-3-整合素 beta1-ERK1/2 和-MMP2 信号传导促进 LoVo 结肠癌细胞的运动、侵袭和转移。
DOI: 10.1186/1476-4598-8-110
发表时间: 2009-11-24
期刊: Molecular cancer
影响因子: 37.3
作者:
Peng L;Xing X;Li W;Qu L;Meng L;Lian S;Jiang B;Wu J;Shou C
通讯作者: Shou C
DOI: 10.1016/0014-5793(95)00947-8
发表时间: 1995-09-18
期刊: FEBS LETTERS
影响因子: 3.5
作者:
CHIARUGI, P;CIRRI, P;RAMPONI, G
通讯作者: RAMPONI, G
DOI: 10.1158/1078-0432.ccr-04-0485
发表时间: 2004-11-01
影响因子: 11.5
作者:
Kato, H;Semba, S;Yokozaki, H
通讯作者: Yokozaki, H
DOI: 10.1074/jbc.m207127200
发表时间: 2002-10-18
影响因子: 4.8
作者:
Kikawa, KD;Vidale, DR;Kinch, MS
通讯作者: Kinch, MS
DOI: 10.1016/j.bbrc.2003.10.126
发表时间: 2003-12-12
影响因子: 3.1
作者:
Rigacci, S;Talini, D;Berti, A
通讯作者: Berti, A